ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NBSE NeuBase Therapeutics Inc

0.378
0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -7.3M-7.72M-9.93M-8.36M-7.72M-4.6M-3.69M-1.96M
Pre Tax Income -7.16M-7.73M-9.92M-8.49M-7.63M-4.37M-3.45M-1.82M
Net Income -7.16M-7.73M-9.92M-8.49M-7.63M-4.37M-3.45M-1.82M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.16M-7.72M-9.92M-8.52M-7.74M-4.52M-4.99M-1.94M
EBITDA -7.15M-7.54M-9.71M-8.16M-7.56M-4.4M-3.51M-1.82M
Year End September 29 2022 20152016201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0710k71k1.23M0000
Operating Income -17.81M-24.6M-23.78M-13.9M-26.34M-17.33M-26.79M-33.73M
Pre Tax Income -15.2M-25.77M-23.81M-13.24M-26.96M-17.39M-25.41M-33.78M
Net Income -15.2M-25.77M-23.81M-13.24M-26.96M-17.39M-25.41M-33.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.501-0.803-0.424-0.234-1.579-0.751-0.777-1.023
EBIT -15.19M-25.78M-23.78M-13.31M-26.34M-16.92M-26.34M-33.9M
EBITDA -16.29M-23.41M-22.61M-6.72M-26.21M-17.13M-26.39M-32.97M